Synthesis 2005(18): 3159-3166  
DOI: 10.1055/s-2005-918426
PAPER
© Georg Thieme Verlag Stuttgart · New York

2-Amino-4-pyrrolidinothieno[2,3-d]pyrimidine-6-carboxylic Acid as an N-Terminal Surrogate in Amino Acid and Peptide Analogues

Evangelos E. Bissyrisa, Dimitris Belekosb, Vassiliki Magafaa, Petros G. Tsoungasc, George Varvounis*b, Paul Cordopatis*a
a Department of Pharmacy, University of Patras, Rio 26504, Greece
Fax: +30(2610)997714; e-Mail: pacord@upatras.gr;
b Department of Chemistry, University of Ioannina, Ioannina 45110, Greece
Fax: +30(26510)98799; e-Mail: gvarvoun@cc.uoi.gr;
c Ministry of Development, Department of Research and Technology, 14-18 Messogion Ave., Athens 11510, Greece
Further Information

Publication History

Received 6 June 2005
Publication Date:
06 October 2005 (online)

Abstract

2-Amino-4-pyrrolidinothieno[2,3-d]pyrimidine-6-carboxylic acid (4) (ATPC) is an unnatural amino acid with promise in applications as a building block for the synthesis of peptidomimetics. ATPC was obtained from both 3a and 3b thienopyrimidines by hydrolysis and hydrogenolysis, respectively. The synthesis of eleven ATPC-amino acids and two ATPC-peptides is described. ATPC is incorporated as N-terminal moiety in solution or solid-phase peptide synthesis using Boc or Fmoc methodology and without protection of the ATPC amino group.

    References

  • 1 Matthew GB. Daniel HR. J. Med. Chem.  2002,  45:  541 
  • 2a In Advances in Amino Acid Mimetics and Peptidomimetics   Vol. 1:  Abell A. JAI Press; Greenwich: 1997. 
  • 2b In Advances in Amino Acid Mimetics and Peptidomimetics   Vol. 2:  Abell A. JAI Press; Greenwich: 1999. 
  • 3a Methods in Molecular Medicine, Peptidomimetics Protocols   Vol. 30:  Kazmierski WM. Walker JM. Human Press; Totowa NJ: 1999. 
  • 3b Plant A. Stieber F. Scherkenbeck J. Lösel P. Dyker H. Org. Lett.  2001,  3:  3427 
  • 3c Abell AD. Lett. Pept. Sci.  2002,  8:  267 
  • 3d Lampariello LA. Piras D. Rodriquez M. Taddei M. J. Org. Chem.  2003,  68:  7893 
  • 4 Roth B. J. Med. Chem.  1969,  12:  227 
  • 5a Varvounis G. Giannopoulos T. Adv. Heterocycl. Chem.  1996,  66:  193 
  • 5b Eguchi J. Saitoh Y. Egawa M. Saito KI. Kawamura H. Pharmacol., Biochem. Behav.  1997,  56:  229 
  • 5c Modica M. Santagati M. Russo F. Parotti L. Gioia L. Selvaggini C. Salmona M. Mennini T. J. Med. Chem.  1997,  40:  574 
  • 5d Katada J. Iijima K. Muramatsu M. Takami M. Yasuda E. Hayashi M. Hattori M. Hayashi Y. Bioorg. Med. Chem. Lett.  1999,  9:  797 
  • 5e Panico A. Cardile V. Santagati A. Gentile B. Farmaco  2001,  56:  959 
  • 5f Sasaki S. Cho N. Nara Y. Harada M. Endo S. Suzuki N. Furuya S. Fujino M. J. Med. Chem.  2003,  46:  113 
  • 5g Munchhof MJ. Beebe JS. Casavant JM. Cooper BA. Doty JL. Higdon RC. Hillerman SM. Soderstrom CI. Knauth EA. Marx MA. Rossi AMK. Sobolov SB. Sun J. Bioorg. Med. Chem. Lett.  2004,  14:  21 
  • 6a Regoli D. Park WK. Rioux F. Pharmacol. Rev.  1974,  26:  69 
  • 6b Khosla MC. Smeby RR. Bumpus FM. In Handbook of Experimental Pharmacology, Angiotensin   Page IH. Bumpus FM. Springer Verlag; Berlin: 1974. 
  • 6c Hardman JG. Goodman Gilmon A. Limbird LE. In Goodman & Gilman’s The Pharmacological Basis of Therapeutics   9th ed.:  McGraw-Hill Companies; New York: 1996. 
  • 6d Miura S. Feng Y.-H. Husain A. Karnik SS. J. Biol. Chem.  1999,  274:  7103 ; and refs therein
  • 7 Clark J. Korakas D. Shahhet MS. Varvounis G. J. Heterocycl. Chem.  1993,  30:  1065 
  • 8a Cordopatis P. Manessi-Zoupa E. Bosse R. Bouley R. Gagnon S. Escher E. Int. J. Pept. Protein Res.  1994,  44:  320 
  • 8b Cordopatis P. Theodoropoulos D. Escher E. In Bioactive Peptides in Drug Discovery and Design   Matsoukas J. Mavromoustakos T. IOS Press; Amsterdam: 1999. 
  • 8c Zalcberg H. Assimomytis N. Magafa V. Manessi-Zoupa E. Cordopatis P. Shimuta SI. J. Pept. Res.  1999,  53:  678 
  • 8d Assimomytis N. Magafa V. Manessi-Zoupa E. Theodoropoulos D. Cordopatis P. Perodin J. Bouley R. Escher E. Arzneimittelforschung/Drug Res.  2000,  50:  526 
  • 9 Spyroulias GA. Nikolakopoulou P. Tzakos A. Gerothanassis IP. Magafa V. Manessi-Zoupa E. Cordopatis P. Eur. J. Biochem.  2003,  270:  2163 
  • 10 Mohamadi F. Richards NGJ. Guida WC. Liskamp R. Caufield C. Chang G. Hendrickson T. Still WC. J. Comput. Chem.  1990,  11:  440 
  • 11 Kolossvary I. Guida WC. J. Am. Chem. Soc.  1996,  118:  5011 
  • 12 Armarego WLF. Perrin DD. Purification of Laboratory Chemicals   Butterworth-Heinemann; Oxford: 1996. 
  • 13 Karagiannis K. Stavropoulos G. Poulos C. Jordan CC. Hagan RM. Int. J. Pept. Protein Res.  1993,  42:  565 
  • 14 Z-Leu-Glu(t-Bu)-NH2 was prepared in 93% yield; mp 139-140 °C, R f 0.80 (BuOH-AcOH-H2O, 4:1:1); R f 0.52 (MeCN-H2O, 7:1); t R = 25.95 min according to: Baumeister B. Matile S. Chem. Eur. J.  2000,  6:  1739 
  • 15 Barlos K. Chatzi O. Gatos D. Stavropoulos G. Int. J. Pept. Protein Res.  1991,  37:  513 
  • 16 Bernatowitz MS. Daniels SB. Köster H. Tetrahedron Lett.  1989,  30:  4645 
  • 17 Kaiser E. Colescott RL. Bossinger CD. Cook PI. Anal. Biochem.  1970,  34:  595 
  • 18 Christensen T. Acta Chem. Scand., Ser. B  1979,  33:  763